Compare SLDB & CTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SLDB | CTRN |
|---|---|---|
| Founded | 2013 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 623.0M | 559.1M |
| IPO Year | 2017 | 2005 |
| Metric | SLDB | CTRN |
|---|---|---|
| Price | $6.17 | $47.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 2 |
| Target Price | $18.71 | ★ $91.00 |
| AVG Volume (30 Days) | ★ 1.3M | 143.9K |
| Earning Date | 11-10-2026 | 12-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 34.97 | ★ 112.14 |
| EPS | N/A | ★ 0.80 |
| Revenue | $8,094,000.00 | ★ $819,962,000.00 |
| Revenue This Year | N/A | $10.94 |
| Revenue Next Year | N/A | $8.69 |
| P/E Ratio | ★ N/A | $60.35 |
| Revenue Growth | N/A | ★ 8.88 |
| 52 Week Low | $3.79 | $35.00 |
| 52 Week High | $11.45 | $77.91 |
| Indicator | SLDB | CTRN |
|---|---|---|
| Relative Strength Index (RSI) | 42.00 | 43.81 |
| Support Level | $5.38 | $47.08 |
| Resistance Level | $6.77 | $52.83 |
| Average True Range (ATR) | 0.46 | 2.30 |
| MACD | 0.12 | 0.50 |
| Stochastic Oscillator | 63.64 | 53.01 |
Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.
Citi Trends Inc is a differentiated off-price value retailer known for trendy fashions, great brands and amazing prices. It is the off-price retailer specifically focused on Black customers, delivering the styles, brands, and trends at amazing prices that resonate with its primary and secondary customers. Its product offering is Women's, Men's and Children's apparel, family footwear, accessories and products for the home, with a three-tiered mix of product. At the opening price point, the company offers value-focused basics for its budget-conscious customers.